1. Home
  2. LITB vs UBX Comparison

LITB vs UBX Comparison

Compare LITB & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LITB
  • UBX
  • Stock Information
  • Founded
  • LITB 2007
  • UBX 2009
  • Country
  • LITB Singapore
  • UBX United States
  • Employees
  • LITB N/A
  • UBX N/A
  • Industry
  • LITB Catalog/Specialty Distribution
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LITB Consumer Discretionary
  • UBX Health Care
  • Exchange
  • LITB Nasdaq
  • UBX Nasdaq
  • Market Cap
  • LITB 32.2M
  • UBX 36.9M
  • IPO Year
  • LITB N/A
  • UBX 2018
  • Fundamental
  • Price
  • LITB $1.01
  • UBX $2.03
  • Analyst Decision
  • LITB
  • UBX Strong Buy
  • Analyst Count
  • LITB 0
  • UBX 2
  • Target Price
  • LITB N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • LITB 11.0K
  • UBX 326.7K
  • Earning Date
  • LITB 03-24-2025
  • UBX 11-04-2024
  • Dividend Yield
  • LITB N/A
  • UBX N/A
  • EPS Growth
  • LITB N/A
  • UBX N/A
  • EPS
  • LITB N/A
  • UBX N/A
  • Revenue
  • LITB $333,093,000.00
  • UBX N/A
  • Revenue This Year
  • LITB N/A
  • UBX N/A
  • Revenue Next Year
  • LITB N/A
  • UBX $33.62
  • P/E Ratio
  • LITB N/A
  • UBX N/A
  • Revenue Growth
  • LITB N/A
  • UBX N/A
  • 52 Week Low
  • LITB $0.91
  • UBX $0.94
  • 52 Week High
  • LITB $6.06
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • LITB 39.01
  • UBX 51.96
  • Support Level
  • LITB $0.91
  • UBX $1.81
  • Resistance Level
  • LITB $1.15
  • UBX $2.39
  • Average True Range (ATR)
  • LITB 0.12
  • UBX 0.25
  • MACD
  • LITB 0.02
  • UBX -0.05
  • Stochastic Oscillator
  • LITB 32.32
  • UBX 34.26

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company is engaged in product sales which consisted of online retailing of consumer products. It also provides services which consisted of the provision of logistic services to e-commerce retailers and small businesses. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: